skip to content
Physiology Preview this item
ClosePreview this item


Author: Sherwood M Reichard; James P Filkins
Publisher: New York : Plenum, ©1985.
Series: Reticuloendothelial system, a comprehensive treatise, v. 7B.
Edition/Format:   Print book : EnglishView all editions and formats

This comprehensive treatise on the reticuloendothelial system is a project jointly shared by individual members of the Reticuloendothelial (RE) Society and bio- medical scientists in general who are  Read more...


(not yet rated) 0 with reviews - Be the first.

More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...


Document Type: Book
All Authors / Contributors: Sherwood M Reichard; James P Filkins
ISBN: 0306414236 9780306414237
OCLC Number: 12036790
Description: xxvi, 533 pages : illustrations ; 27 cm.
Contents: IV. Regulation and Macrophage Secretions.- 1. Endocrinelike Activities of the RES: An Overview.- 1. Introduction.- 2. Macrophage Factors Regulating Lymphocyte Functions.- 2.1. Interleukin 1 (Lymphocyte-Activating Factor).- 2.2. Thymic Maturation Factor.- 2.3. Genetically Related Factor.- 2.4. Interferon.- 2.5. Glucocorticoid Response-Modifying Factor.- 2.6. Prostaglandins and Oxygen Metabolites.- 3. Macrophage Factors Regulating Nonlymphoid Cells.- 3.1. Leukocytic Endogenous Mediator (Endogenous Pyrogen).- 3.2. Synovial Cell- and Chondrocyte-Stimulating Factors.- 3.3. Serum Amyloid A-Inducing Factor.- 3.4. Fibroblast-Activating Factor and Corneal Cell Factor.- 3.5. Glucocorticoid-Antagonizing Factor and Macrophage Insulinlike Activity.- 4. Macrophage Factors Regulating Cells of the RES.- 4.1. Colony-Stimulating Factor and Factor Inducing Monocytopoiesis.- 4.2. Interferon.- 4.3. Prostaglandins.- 5. Concluding Remarks.- References.- 2. Regulation of Complement Synthesis in Mononuclear Phagocytes.- 1. Introduction.- 2. Historical.- 3. Systems Used to Assay for Synthesis of Complement Proteins.- 4. Regulation of Complement Synthesis by Mononuclear Phagocytes.- 4.1. Posttranslational Modification.- 4.2. Effect of Agents Used to Induce a Peritoneal Exudate.- 4.3. Percentage of Mononuclear Phagocytes That Synthesize Complement.- 4.4. Effect of Phagocytosis.- 4.5. Kinetics of Complement Production by Human Peripheral Blood Monocytes and the Effect of Lymphokine on the Rate and Extent of Production.- 4.6. Effect of Culture Surfaces on Capacity of Macrophages and Monocytes to Produce Complement.- 4.7. Effect of Cortisone and Cyclophosphamide.- 4.8. Alteration of Complement Synthesis during Disease States.- 4.9. Miscellaneous.- References.- 3. The Synthesis of Arachidonic Acid Oxygenation Products by Macrophages.- 1. Introduction.- 2. Synthesis of Arachidonic Acid Oxygenation Products via the Cyclooxygenase Pathway in Mononuclear Phagocytes.- 2.1. Mouse Peritoneal Macrophages.- 2.2. Regulation of Prostaglandin Synthesis by Mouse Peritoneal Macrophages.- 2.3. The Phospholipases of Mouse Peritoneal Macrophages.- 2.4. Prostaglandin Synthesis by Mouse Peritoneal Macrophages Is Dependent on RNA and Protein Synthesis.- 2.5. Variations in the Nature and Extent of Cyclooxygenase Product Formation by Resident and Elicited Mouse Peritoneal Macrophages and Mononuclear Phagocytes from Other Sources in the Mouse.- 2.6. The Synthesis of Products of the Cyclooxygenase Pathway by Human Peripheral Blood Monocytes.- 3. Synthesis of Lipoxygenase Pathway Products by Macrophages.- 4. Concluding Remarks.- References.- 4. Lysosomal Hydrolases.- 1. Introduction.- 2. The Monocyte Granules.- 3. From Monocytes to Macrophages.- 4. The Lysosomal Apparatus of Macrophages.- 4.1. Introduction.- 4.2. Subcellular Fractionation of Alveolar Macrophages.- 4.3. Subcellular Fractionation of Peritoneal Macrophages and Bone Marrow-Derived Macrophages.- 4.4. Ultrastructure of Alveolar and Peritoneal Macrophages.- 5. Lysosomal Enzyme Levels in Differentiating Macrophages.- 6. The Release of Lysosomal Enzymes from Macrophages.- 6.1. Release into Phagocytic Vacuoles.- 6.2. Release by Secretion.- 7. Stimulus-Induced Secretion of Lysosomal Enzymes.- 7.1. Induction by Phagocytosis.- 7.2. Induction by Nonphagocytic Stimuli.- 7.3. The Mechanism of Lysosomal Enzyme Secretion by Macrophages.- References.- 5. Macrophage Neutral Proteinases: Nature, Regulation, and Role.- 1. Introduction.- 2. Nature of Macrophage Neutral Proteinases.- 2.1. Background.- 2.2. General Aspects.- 2.3. Plasminogen Activator.- 3. Localization of Macrophage Neutral Proteinases.- 3.1. General Considerations.- 3.2. Plasminogen Activator.- 4. Regulation of Neutral Proteinase Activities in Macrophages.- 4.1. General Considerations.- 4.2. Inflammation.- 4.3. Endotoxin.- 4.4. Surface Receptors and Endocytosis.- 4.5. Immune Regulation.- 4.6. Colony-Stimulating Factors.- 4.7. Hormonal and Pharmacological Control.- 4.8. Proteinases, Peptides, and Antiproteinases.- 5. Role of Proteinase in Macrophage Function.- 5.1. General Comments.- 5.2. Fibrinolysis.- 5.3. Activation of Plasma Proteinase Cascades.- 5.4. Catabolism of Connective Tissue and Other Proteins.- 5.5. Cell Surfaces, Adherence, and Endocytosis.- 5.6. Macrophage Activation.- 5.7. Macrophage Proliferation.- 5.4. Prostaglandin Synthesis.- 6. Addendum.- 7. Conclusion.- References.- 6. Interferon and Macrophages.- 1. Introduction.- 2. Macrophages as Producers of Interferon.- 3. Inducers for Macrophage Interferon Production.- 4. Importance of the Degree of Maturation of the Macrophage for Interferon Production.- 5. Relationships of Macrophage Interferon to Other Macrophage Products.- 6. Kinetics and Process of Interferon Induction in Macrophages.- 7. The Macrophage as an Accessory Cell for Interferon Production.- 8. The Role of Macrophages for in Vivo Interferon Production.- 9. Effects of Interferon on Macrophages.- 10. Concluding Comments.- References.- 7. Leukocytic Endogenous Mediator in Nonspecific Host Defenses.- 1. Introduction.- 2. Isolation of LEM and Its Physiochemical Properties.- 2.1. Isolation and Purification.- 2.2. Physiochemical Properties.- 2.3. Differentiation from Bacterial Endotoxin.- 3. Comparison of LEM to IL-1 and EP.- 4. Cells and Conditions Involved in Production and Release of LEM.- 4.1. Cells Which Produce LEM.- 4.2. Activation of Cells to Release LEM.- 4.3. Synthesis and Release Conditions.- 5. Biological Activities of LEM.- 5.1. Neutrophilia and Granulopoiesis.- 5.2. Zinc Metabolism.- 5.3. Iron Metabolism.- 5.4. Copper Metabolism.- 5.5. Acute-Phase Proteins.- 5.6. Protection against Bacterial Infection.- 5.7. Other Biological Activities.- 6. Summary.- References.- V. Clinical Physiology of the RES.- 8. Evaluation of RES Clearances in Man.- 1. Introduction.- 2. Methods Available for Evaluation of RES Clearances in Man.- 2.1. Detection and Measurement of Spillover of Endogenous Substances.- 2.2. Clearance of Exogenous Test Particles Injected Intravenously.- 2.3. Investigation of Stages in RES Clearances.- 3. Conclusions.- References.- 9. RES Function in Experimental and Human Liver Disease.- 1. Introduction.- 2. RES Function in Experimental Liver Disease Related to Human Abnormalities.- 2.1. Acute Liver Disease.- 2.2. Chronic Liver Disease.- 2.3. Summary: Influence of Experimental Liver Disease on RES Function.- 3. RES Function in Human Liver Disease.- 3.1. RES Function and Acute Liver Disease.- 3.2. RES Function and Acute Alcoholic Liver Disease.- 3.3. RES Function and Chronic Liver Disease.- 4. Summary and Perspective.- References.- 10. Regional Phagocytosis in Man.- 1. Introduction.- 2. The Liver.- 2.1. Radiopharmaceuticals.- 2.2. The Normal Liver.- 2.3. The Liver Scan in Disease.- 3. The Spleen.- 3.1. Radiopharmaceuticals.- 3.2. The Normal Spleen.- 3.3. The Spleen Scan in Disease.- 4. Bone Marrow.- 4.1. Radiopharmaceuticals.- 4.2. The Normal Bone Marrow.- 4.3. Bone Marrow Scans in Disease.- 5. The Lymph System.- 5.1. Radiopharmaceuticals.- 5.2. The Normal Lymph Node.- 5.3. Lymph Node Imaging in Disease.- References.- 11. Inflammatory Cell Dynamics in Man.- 1. Definitions.- 1.1. Acute Inflammation Due to Trauma.- 1.2. Acute Immune Response in Inflammation.- 1.3. The Lymphocyte in Man.- 1.4. The Monocyte in Man.- 2. Observations on the Cell-Mediated Immune Response and the Sequence of Leukocytic Migrations.- 2.1. The Acute Immune Response in Inflammation in Man.- 2.2. Phagocytic Activity of Transforming Lymphocytes in Inflammation in Man.- 3. Critique.- 3.1. Immunological Dissection of Leukocytic Inflammatory Responses in Skin Windows in Man.- 3.2. Leukocytic Responses to Abnormal Inflammatory Stimuli.- 3.3. Abnormal Leukocytic Responses to Normal Inflammatory Stimuli.- 4. Discussion.- 4.1. Neutrophilic Functions.- 4.2. The Monocyte of Man in Inflammation.- 4.3. The Lymphocyte in Man: Amplification and Dynamism in Inflammation.- 5. Summary.- References.- 12. Fibronectin and Reticuloendothelial Clearance of Blood-Borne Particles: Clinical Studies in Septic Shock.- 1. Introduction.- 2. Opsonic Glycoprotein (Plasma Fibronectin) Depletion and Particulate Removal.- 3. Reticuloendothelial Systemic Defense and Traumatic Injury.- 4. Organ Failure in Shock and RE Function.- 5. Opsonic ?2-SB Glycoprotein and Plasma Fibronectin.- 6. Cell Surface Fibronectin as Related to Plasma Fibronectin.- 7. Cryoprecipitate Infusion and Organ Function in Septic Injured Patients.- 8. Microvascular Fluid and Solute Exchange and Fibronectin.- 9. Antibacterial Defense by Phagocytosis and Fibronectin.- 10. Conclusions and Significance.- References.- VI. Integrative Functions of the RES.- 13. Physiology and Pathophysiology of Pulmonary Macrophages.- 1. Introduction.- 2. Types of Pulmonary Macrophages.- 3. Origin of Pulmonary Macrophages.- 4. Fate of Pulmonary Macrophages.- 5. Quantitation and Harvesting Techniques.- 6. Role of Pulmonary Macrophages.- 7. Pathophysiology of Pulmonary Macrophages.- 8. Conclusion.- References.- 14. Temperature Regulation and Fever.- 1. Introduction.- 2. Basic Thermal Physiology.- 3. Neuronal Integration during Fever.- 3.1. General Consideration.- 3.2. The CNS and Fever.- 4. Leukocyte Pyrogen.- 4.1. Characteristics.- 4.2. Nonpyrogenic Effects of LP.- 4.3. Immune Fever.- 4.4. LP as a Monokine.- 5. Cell Sources of LP.- 5.1. Historical Background.- 5.2. Characteristics of LP Release from Mononuclear Phagocytes.- 5.3. Kupffer Cells.- 6. Summary.- References.- 15. Microcirculatory Regulation and Dysfunction: Relationship to RES Function and Resistance to Shock and Trauma.- 1. Introduction.- 2. Microcirculation.- 2.1. Architecture, Ultrastructure, and Density of Adrenergic Innervation.- 2.2. Function and Regulation.- 2.3. Criteria for a Substance to Be Classified a Local Regulator of Blood Flow.- 2.4. Important Candidates for Regulators of Blood Flow.- 3. Microcirculatory Dysfunction in Circulatory Shock and Trauma.- 3.1. Failure of Local Vascular-Homeostatic Mechanisms.- 3.2. Vasoactive Mediators in Circulatory Shock and Low-Flow States.- 4. RE Cell Function in Recognition and Treatment of Circulatory Shock and Trauma.- 4.1. Overview of Circulatory Shock Problem.- 4.2. RES Phagocytic Function as a Tissue-Level Index of the Course of Shock and Low-Flow State Syndrome.- 4.3. RES-Stimulating Materials Compatible for Human Use: Prophylactic Treatment for Circulatory Shock.- 5. Specific RE Cell-Microcirculatory Interactions in Shock, Trauma, and Systemic Stress.- 5.1. RE Cell Colloid Stimulants Prevent Loss of Venular Tone in Circulatory Shock and Trauma.- 5.2. Estrogenic and Glucocorticoid Steroids Normalize Microvascular Tone in Circulatory Shock and Trauma: Temporal Relationship to Effects on the RES.- 5.3. Vasoactive Peptide Pressor Analogs with Selective Microvascular Actions Improve Survival and RE Cell Function in Shock and Trauma Syndromes.- 6. Conclusions.- References.- 16. Radiation Effects on Phagocytic Cells of the RES.- 1. Introduction.- 2. Alterations of RES Cell Structure.- 3. Changes of Phagocytic Cell Function.- 3.1. Irradiation in Vitro.- 3.2. Irradiation in Vivo.- 4. Changes of Global RES Phagocytic Function.- 4.1. Inorganic Colloids: Chromium Phosphate, Saccharated Iron Oxide, Radiogold, Thorotrast, Prodigiosin.- 4.2. Carbon Clearance.- 5. Handling of Bacteria and Antigens by Macrophages.- 5.1. Bacterial Clearance.- 5.2. Intracellular Digestive Function of Macrophages.- 6. Presentation of Antigen.- 7. Biochemical Properties.- 8. Altered Response of the RES in Whole-Body-Irradiated Animals.- 8.1. Alteration in Drug Response.- 8.2. Enhancement of Particle-Induced RES Blockade.- 8.3. Potentiation of the Response to Stress.- 8.4. Mechanisms of Depression of RES Response.- 9. Oxygen Metabolism.- 10. Protection against Radiation Lethality.- 11. Conclusion.- References.- 17. Role of the Reticuloendothelial System in Shock.- 1. Introduction.- 2. Evidence for RES Involvement in Shock.- 2.1. General Observations.- 2.2. RES Blockade.- 2.3. RES Stimulation.- 2.4. RES Activity in Shock.- 2.5. Effect of Macrophage Heterogeneity on Responses to Trauma.- 2.6. Role of the RES in Immune Suppression following Traumatic Shock.- 2.7. Effect of Trauma on RE Cells in the Lung.- 2.8. Effect of Adrenal Cortical Hormones on RES Function following Trauma.- 2.9. Effect of Other Hormones on RES Function following Trauma.- 2.10. Effect of Trauma on RE Cell Energy Metabolism.- 2.11. Effect of Starvation on Susceptibility to Shock Induction.- 2.12. Effect of Cancer on Susceptibility to Shock Induction.- 3. Effect of Trauma-Sensitive Factors on RES and Shock Induction.- 3.1. Role of Lysosomal Enzymes in the Pathogenesis of Shock.- 3.2. Effect of Released Tissue Debris on RES Function.- 3.3. Effect of Fibronectin Depletion on RES Function.- 3.4. RE Cell Depressant Substance.- 3.5. Role of Prostaglandins in Shock.- 3.6. Toxic Oxygen Products.- 4. Regulatory Role of Trauma-Sensitive Serum Factors on RES Activity.- 4.1. C-Reactive Protein.- 4.2. Ceruloplasmin.- 4.3. Role of Fibronectin in Shock.- 4.4. The Effect of Complement Activation on Shock Induction and RES Function.- 4.5. Trauma-Protecting Factors.- 4.6. Histamine.- 5. Summary: Mechanism of Shock Induction and Protective Activity of the RES.- References.- 18. Toxic Oxygen Products in Shock.- 1. Introduction.- 2. Toxic Oxygen Products.- 2.1. Cytotoxic Action.- 2.2. Inactivation of Antiproteases.- 2.3. Prostaglandin, Thromboxane, and Leukotriene Generation.- 3. Protective Mechanisms against Toxic Oxygen Products.- 3.1. Plasma Factors.- 3.2. Cellular Factors.- 4. Glutathione.- 4.1. Glutathione Deficiencies.- 4.2. Traumatic Shock.- 5. Addition of Scavengers.- 5.1. Glutathione.- 5.2. Superoxide Dismutase.- 5.3. Other Radical Scavengers.- 5.4. Corticosteroids.- 6. Complement Activation.- 7. Shock Induction.- 7.1. Anaphylatoxins.- 7.2. Toxic Oxygen Products.- 8. Summary.- References.- 19. The RES and the Turnover of Circulating Lysosomal Enzymes in Shock.- 1. Introduction.- 2. Release of Lysosomal Enzymes in Shock.- 2.1. RE Function, Shock Tolerance, and Enzyme Release.- 2.2. Role of Single Organs in Enzyme Turnover.- 2.3. Cellular Origin of Lysosomal Enzymes.- 3. RES and Enzyme Elimination.- 3.1. Lysosomal Enzymes as Shock Toxins.- 3.2. Clinical Evidence for Enzyme Elimination.- 3.3. Hepatic Receptors and Clearance of Lysosomal Enzymes.- 4. Balance of Circulating Lysosomal Enzymes.- 5. Summary.- References.
Series Title: Reticuloendothelial system, a comprehensive treatise, v. 7B.
Responsibility: edited by Sherwood M. Reichard and James P. Filkins.


User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...


Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

Primary Entity

<> # Physiology
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "12036790" ;
    library:placeOfPublication <> ; # New York
    library:placeOfPublication <> ;
    schema:about <> ; # Mononuclear Phagocyte System--physiology
    schema:about <> ; # Système réticuloendothélial
    schema:about <> ; # Physiologie
    schema:about <> ; # Système réticulo-endothélial
    schema:about <> ; # Macrophages
    schema:about <> ;
    schema:bookFormat bgn:PrintBook ;
    schema:contributor <> ; # James P. Filkins
    schema:contributor <> ; # Sherwood M. Reichard
    schema:copyrightYear "1985" ;
    schema:datePublished "1985" ;
    schema:exampleOfWork <> ;
    schema:inLanguage "en" ;
    schema:isPartOf <> ; # Reticuloendothelial system, a comprehensive treatise ;
    schema:name "Physiology"@en ;
    schema:productID "12036790" ;
    schema:publication <> ;
    schema:publisher <> ; # Plenum
    schema:workExample <> ;
    wdrs:describedby <> ;

Related Entities

<> # New York
    a schema:Place ;
    schema:name "New York" ;

<> # Reticuloendothelial system, a comprehensive treatise ;
    a bgn:PublicationSeries ;
    schema:hasPart <> ; # Physiology
    schema:name "Reticuloendothelial system, a comprehensive treatise ;" ;

<> # Macrophages
    a schema:Intangible ;
    schema:name "Macrophages"@en ;
    schema:name "Macrophages"@fr ;

<> # Mononuclear Phagocyte System--physiology
    a schema:Intangible ;
    schema:name "Mononuclear Phagocyte System--physiology"@en ;

<> # Système réticulo-endothélial
    a schema:Intangible ;
    schema:name "Système réticulo-endothélial"@fr ;

<> # Système réticuloendothélial
    a schema:Intangible ;
    schema:name "Système réticuloendothélial"@en ;

<> # Sherwood M. Reichard
    a schema:Person ;
    schema:birthDate "1928" ;
    schema:familyName "Reichard" ;
    schema:givenName "Sherwood M." ;
    schema:name "Sherwood M. Reichard" ;

<> # James P. Filkins
    a schema:Person ;
    schema:familyName "Filkins" ;
    schema:givenName "James P." ;
    schema:name "James P. Filkins" ;

    a schema:ProductModel ;
    schema:isbn "0306414236" ;
    schema:isbn "9780306414237" ;

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.